z-logo
open-access-imgOpen Access
Antiherpetic Effects ofGynura procumbens
Author(s) -
Siripen Jarikasem,
Somyot Charuwichitratana,
Sontana Siritantikorn,
Wasan Chantratita,
Magdy Iskander,
August Wilhelm Frahm,
Weena Jiratchariyakul
Publication year - 2013
Publication title -
evidence-based complementary and alternative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.552
H-Index - 90
eISSN - 1741-4288
pISSN - 1741-427X
DOI - 10.1155/2013/394865
Subject(s) - stigmasterol , herpes simplex virus , ethanol , ic50 , placebo , traditional medicine , chemistry , methanol , chromatography , titer , phytotherapy , pharmacology , medicine , virus , in vitro , virology , biochemistry , organic chemistry , alternative medicine , pathology
The ethanol extract of Gynura procumbens showed virucidal and antireplicative actions against herpes simplex virus HSV-1 and HSV-2. It was further chromatographed on MCI gel CHP20P column giving the extract fractions F1 (water), F2 (water-methanol) F3 (methanol), and F4 (ethyl acetate). All but F1 had virucidal action against both viral types. We reported here the active compounds from F2 and F3. The antiherpetic compounds of F2 was a mixture of dicaffeoylquinic acids with virucidal and antireplicative actions against HSV-2 (IC 50 96.0 and 61.0  μ g/mL, resp.) Virucidal compounds of F3 were a mixture of β -sitosterol and stigmasterol (IC 50 250.0  μ g/mL against HSV-1), a mixture of β -sitosteryl and stigmasteryl glucosides (IC 50 50.0  μ g/mL against HSV-2) and 1, 2-bis-dodecanoyl-3- α -D-glucopyranosyl- sn -glycerol (IC 50 of 40.0  μ g/mL against HSV-2). Herbal products containing 1 and 2% of standardized ethanol extract were prepared. Double-blind randomized controlled clinical trial of the products was performed in patients with recurrent herpes labialis. Results showed that the number of patients, whose lesions healed within 7 days and the average healing time of both groups differed insignificantly. Viral culture on D7 indicated a decrease of infected patients from 48.7% to 7.69% in treated group whereas in placebo group the infected patients decreased from 31.25% to 20.00%. The viral reduction in treated group indicated the benefit of the product. Insignificant result might arise from a low number of participated patients and insufficient concentration of plant extract in herbal product.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom